HTR1A, 5-hydroxytryptamine receptor 1A, 3350

N. diseases: 229; N. variants: 9
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0003467
Disease: Anxiety
Anxiety
0.100 GeneticVariation disease BEFREE Polymorphisms in genes coding for the serotonin receptor subtype 1A (HTR1A), the serotonin transporter (SLC6A4), and the serotonin degrading enzyme monoamine oxidase A (MAOA) are associated with anxiety, impulsivity, and neurotic personality in humans. 31045220 2019
CUI: C0003467
Disease: Anxiety
Anxiety
0.100 Biomarker disease BEFREE The selective serotonin reuptake inhibitor fluoxetine and the 5-HT1A receptor agonist buspirone are used to treat depression and anxiety. 31244623 2019
CUI: C0003467
Disease: Anxiety
Anxiety
0.100 Biomarker disease BEFREE These results suggest that markedly reduced 5-HT1A autoreceptors may provide a marker for aberrant response to SSRI treatment.<b>SIGNIFICANCE STATEMENT</b> Serotonin-selective reuptake inhibitors (SSRIs) are effective in treating anxiety and depression in humans and mouse models. 30552180 2019
CUI: C0003467
Disease: Anxiety
Anxiety
0.100 GeneticVariation disease BEFREE We thus conducted a structural equation model (SEM) to examine whether the HTR1A rs6295 variant can affect anxiety by altering parasympathetic nervous activity. 29363117 2018
CUI: C0003467
Disease: Anxiety
Anxiety
0.100 AlteredExpression disease BEFREE Targeting specific transcription factors, such as Freud-1, to restore transcriptional balance may augment response to antidepressant treatment.<b>SIGNIFICANCE STATEMENT</b> Altered regulation of the 5-HT1A autoreceptor has been implicated in human anxiety, major depression, suicide, and resistance to antidepressants. 29101244 2017
CUI: C0003467
Disease: Anxiety
Anxiety
0.100 AlteredExpression disease BEFREE electronic database was used as source of the studies selected selected based on the studies found by crossing the following keywords: cannabidiol and panic disorder; canabidiol and anxiety, cannabidiol and 5-HT1A receptor). 27157263 2017
CUI: C0003467
Disease: Anxiety
Anxiety
0.100 GeneticVariation disease BEFREE The aim was to further characterize the impact of cue acquisition and trait anxiety, and of a single nucleotide polymorphism in the serotonin 1A receptor gene (5-HTR1A, rs6295), on cued fear and contextual anxiety before and after fear contingencies were explicitly introduced. 25448266 2015
CUI: C0003467
Disease: Anxiety
Anxiety
0.100 AlteredExpression disease BEFREE Transcriptional dys-regulation in anxiety and major depression: 5-HT1A gene promoter architecture as a therapeutic opportunity. 24180393 2014
CUI: C0003467
Disease: Anxiety
Anxiety
0.100 Biomarker disease BEFREE In this review, we examine the function of 5-HT(1A) receptor subpopulations and re-interpret our understanding of their role in mental illness in light of new data, separating both spatial (autoreceptor versus heteroreceptor) and the temporal (developmental versus adult) roles of the endogenous 5-HT(1A) receptors, emphasizing their distinct actions in mediating anxiety and depression-like behaviors. 24337875 2014
CUI: C0003467
Disease: Anxiety
Anxiety
0.100 Biomarker disease BEFREE This work indicates that the effects of 5-HT1A autoreceptors on anxiety and social behaviors are developmentally mediated and suggests that natural variations in the expression of 5-HT1A may act during development to influence individual anxiety levels and contribute to susceptibility to anxiety disorders. 23907404 2014
CUI: C0003467
Disease: Anxiety
Anxiety
0.100 AlteredExpression disease BEFREE Targeted therapeutics to inhibit 5-HT(1A) autoreceptor expression and induce 5-HT(1A) heteroreceptor expression may ameliorate treatment of anxiety and major depression. 22826341 2012
CUI: C0003467
Disease: Anxiety
Anxiety
0.100 Biomarker disease BEFREE We investigated the possible association between depression and anxiety scores and SNPs within the HTR1A and HTR1B genes in a population sample (n=1387). 20638825 2011
CUI: C0003467
Disease: Anxiety
Anxiety
0.100 GeneticVariation disease BEFREE Only the G allele of HTR1A rs6295 seemed to increase the risk of emotional-dramatic cluster B personality disorders (p = 0.019, in the personality disorder sample) and to decrease the risk of anxious-fearful cluster C personality disorders (p = 0.016, in the aADHD sample). 19894072 2010
CUI: C0003467
Disease: Anxiety
Anxiety
0.100 Biomarker disease BEFREE The 5-HT(1A) receptor is a metabotropic G protein-coupled receptor linked to the G(i/o) signaling pathway and has been specifically implicated in the pathogenesis of depression and anxiety. 20643652 2010
CUI: C0003467
Disease: Anxiety
Anxiety
0.100 Biomarker disease BEFREE In healthy subjects, increased anxiety scores might be associated with lower 5-HT1A receptor binding. 19423077 2009
CUI: C0003467
Disease: Anxiety
Anxiety
0.100 AlteredExpression disease BEFREE Altered expression of serotonin-1A (5-HT1A) receptors, both presynaptic in the raphe nuclei and post-synaptic in limbic and cortical target areas, has been implicated in mood disorders such as major depression and anxiety. 19423080 2009
CUI: C0003467
Disease: Anxiety
Anxiety
0.100 Biomarker disease BEFREE Our findings further implicate relatively increased serotonin signaling, associated with a genetic variation that mediates increased 5-HT(1A) autoreceptors, in driving amygdala reactivity and trait anxiety. 19124686 2009
CUI: C0003467
Disease: Anxiety
Anxiety
0.100 AlteredExpression disease BEFREE As such, the level of expression of 5-HT1A receptors is implicated in the development of anxiety and depression phenotypes. 18639564 2008
CUI: C0003467
Disease: Anxiety
Anxiety
0.100 Biomarker disease BEFREE In this study, we examined the serotonin 1A receptor gene, HTR1A, for its association with shared genetic risk across a range of anxiety and depression-related phenotypes. 18163385 2008
CUI: C0003467
Disease: Anxiety
Anxiety
0.100 Biomarker disease BEFREE While multiple lines of evidence implicate the 5-HT1A receptor in the pathophysiology of anxiety and depression as well as in the mechanism of action of anxiolytics/antidepressants, its relevance to the therapeutic effectiveness of these drugs has been a matter of considerable debate (for review see Griebel, 1995; Hensler, 2003; Hjorth et al., 2000; Lesch et al., 2003). 15683551 2004
CUI: C0003467
Disease: Anxiety
Anxiety
0.100 GeneticVariation disease BEFREE A functional promoter polymorphism in the serotonin receptor 1A (5-HT1A) gene has been found to be associated with major depression as well as anxiety- and depression-related personality traits. 14984628 2004
CUI: C0003467
Disease: Anxiety
Anxiety
0.100 AlteredExpression disease BEFREE Our findings indicate a role of allelic variation in 5-HT1A receptor expression in the development and modulation of anxiety- and depression-related personality traits. 14666415 2003
CUI: C0003467
Disease: Anxiety
Anxiety
0.100 Biomarker disease BEFREE In this paper, studies focusing on anxiety using 5-HT1A receptor knockout (1AKO) and 5-HT1B receptor knockout (1BKO) mice are reviewed. 14501251 2003
CUI: C0003467
Disease: Anxiety
Anxiety
0.100 Biomarker disease BEFREE Mice lacking the 5-HT1A have been found to be more anxious in several behavioral paradigms. 11374326 2001
CUI: C0003467
Disease: Anxiety
Anxiety
0.100 Biomarker disease BEFREE The serotonin system, and the serotonin(1A) (5-HT(1A)) receptor in particular, have been under intense investigation, mostly due to the fact that serotonergic drugs that directly or indirectly affect the 5-HT(1A) receptor, are effective therapeutic agents in treating patients with various neuropsychiatric disorders, including anxiety and depression. 11704418 2001